Finance News – Drug Manufacturing
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Stock
Investors
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Etf
Bse
Earnings
Ipo
Stablecoin
Investment
Blockchain
Revenue
Solana
Index
Trade
Sec
Inflation
Interest Rates
Wall Street
Token
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Profit
Nse
China
Nifty
Bse Sensex
Sp 500
Investor
Gold
Tesla
Company
Economy
Grams
Customer Base
Equity Investment
Rotation
Dollar Strength
Gross Bookings
Full Year Sales
Market Movers
Remote Working
Home Owners
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
The Guardian – Business • Jul 22, 2025
AstraZeneca to invest $50bn in US by 2030 amid Trump tariff threats
AstraZeneca plans to allocate $50 billion over the next decade to enhance manufacturing and research capabilities across multiple US states, reflecting a strategic commitment amid...
Read Full Article →
CNBC Business • May 05, 2025
Trump signs order to boost domestic drug manufacturing as pharma tariffs loom
The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.
Read Full Article →